PubMed:32676695 / 0-318 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":114,"end":122},"obj":"Disease"},{"id":"T2","span":{"begin":125,"end":134},"obj":"Disease"},{"id":"T3","span":{"begin":224,"end":232},"obj":"Disease"},{"id":"T4","span":{"begin":235,"end":244},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.\nINTRODUCTION: Most of the drugs associations that have been used to treat patients with SARS-CoV-2 infection increase the risk of prolongation of the corrected QT interval (QTc).\nOBJ"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":26,"end":44},"obj":"Chemical"},{"id":"T2","span":{"begin":61,"end":70},"obj":"Chemical"},{"id":"T3","span":{"begin":71,"end":80},"obj":"Chemical"},{"id":"T4","span":{"begin":84,"end":96},"obj":"Chemical"},{"id":"T5","span":{"begin":162,"end":167},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_367163"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.\nINTRODUCTION: Most of the drugs associations that have been used to treat patients with SARS-CoV-2 infection increase the risk of prolongation of the corrected QT interval (QTc).\nOBJ"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":135},"obj":"Sentence"},{"id":"T2","span":{"begin":136,"end":149},"obj":"Sentence"},{"id":"T3","span":{"begin":150,"end":314},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.\nINTRODUCTION: Most of the drugs associations that have been used to treat patients with SARS-CoV-2 infection increase the risk of prolongation of the corrected QT interval (QTc).\nOBJ"}